טוען...
Association of Baseline Visual Acuity and Retinal Thickness With 1-year Efficacy of Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema
IMPORTANCE: Comparisons of the relative effect of three anti-vascular endothelial growth factor (anti-VEGF) agents to treat DME warrant further assessment. OBJECTIVE: P rovide additional outcomes from a randomized trial evaluating three anti-VEGF agents for DME within subgroups based on baseline vis...
שמור ב:
| הוצא לאור ב: | JAMA Ophthalmol |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2016
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5567793/ https://ncbi.nlm.nih.gov/pubmed/26605836 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaophthalmol.2015.4599 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|